These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 16137512
21. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. López-Alonso M, Moya MJ, Cabo JA, Ribas J, del Carmen Macías M, Silny J, Sifrim D. Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894 [Abstract] [Full Text] [Related]
22. Duodenogastro-esophageal reflux in children with refractory gastro-esophageal reflux disease. Hoffman I, Tertychnyy A, Ectors N, De Greef T, Haesendonck N, Tack J. J Pediatr; 2007 Sep; 151(3):307-11. PubMed ID: 17719945 [Abstract] [Full Text] [Related]
23. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease. Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M, Rosano GM. Int J Cardiol; 2007 Aug 09; 120(1):79-84. PubMed ID: 17134770 [Abstract] [Full Text] [Related]
24. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. Williams RB, Szczesniak MM, Maclean JC, Brake HM, Cole IE, Cook IJ. Am J Gastroenterol; 2004 May 09; 99(5):777-85. PubMed ID: 15128336 [Abstract] [Full Text] [Related]
25. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ. Am J Gastroenterol; 2008 Oct 09; 103(10):2446-53. PubMed ID: 18684197 [Abstract] [Full Text] [Related]
26. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy? Beaumont H, Boeckxstaens GE. Am J Gastroenterol; 2009 Jul 09; 104(7):1764-71. PubMed ID: 19491837 [Abstract] [Full Text] [Related]
27. Characteristics and clinical relevance of proximal esophageal pH monitoring. Cool M, Poelmans J, Feenstra L, Tack J. Am J Gastroenterol; 2004 Dec 09; 99(12):2317-23. PubMed ID: 15571576 [Abstract] [Full Text] [Related]
28. [Sinoatrial block caused by gastroesophageal reflux. The role of simultaneous 24 hr. esophageal pH-metry and Holter-ECG in the differential diagnosis of angina pectoris]. Patai A, Sipos E, Döbrönte Z. Orv Hetil; 1996 Mar 31; 137(13):687-90. PubMed ID: 8649749 [Abstract] [Full Text] [Related]
29. Typical GERD symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux. Oelschlager BK, Chang L, Pope CE, Pellegrini CA. J Surg Res; 2005 Sep 31; 128(1):55-60. PubMed ID: 16115493 [Abstract] [Full Text] [Related]
30. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily. Gasiorowska A, Navarro-Rodriguez T, Wendel C, Krupinski E, Perry ZH, Koenig K, Moty B, Powers J, Fass R. Am J Gastroenterol; 2009 Aug 31; 104(8):2005-13. PubMed ID: 19491829 [Abstract] [Full Text] [Related]
31. High prevalence of gastroesophageal reflux in patients with clinical unstable angina and known coronary artery disease. Schultz T, Mannheimer C, Dellborg M, Pilhall M, Börjesson M. Acute Card Care; 2008 Aug 31; 10(1):37-42. PubMed ID: 17851977 [Abstract] [Full Text] [Related]
32. The use of pH monitoring and esophageal manometry in the evaluation of results of surgical therapy for gastroesophageal reflux disease. Soyer T, Karnak I, Tanyel FC, Senocak ME, Ciftci AO, Büyükpamukçu N. Eur J Pediatr Surg; 2007 Jun 31; 17(3):158-62. PubMed ID: 17638153 [Abstract] [Full Text] [Related]
33. Effect of hyoscine N-butylbromide on gastroesophageal reflux in normal subjects and patients with gastroesophageal reflux disease. Ciccaglione AF, Grossi L, Cappello G, Malatesta MG, Ferri A, Toracchio S, Marzio L. Am J Gastroenterol; 2001 Aug 31; 96(8):2306-11. PubMed ID: 11519531 [Abstract] [Full Text] [Related]
35. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, Schrijver M, Dieleman LA, Meuwissen SG. Am J Gastroenterol; 1997 Nov 31; 92(11):1997-2000. PubMed ID: 9362179 [Abstract] [Full Text] [Related]
36. Effect of sodium valproate on esophageal motility in healthy subjects and patients with gastroesophageal reflux. Tzovaras G, Tsiaoussis J, Athanasakis E, Zoras O, Xynos E, Chrysos E. Scand J Gastroenterol; 2004 Jun 31; 39(6):521-6. PubMed ID: 15223674 [Abstract] [Full Text] [Related]
37. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients. Weigt J, Kandulski A, Büsch F, Malfertheiner P. Dig Dis; 2009 Jun 31; 27(1):68-73. PubMed ID: 19439964 [Abstract] [Full Text] [Related]
39. The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial. Budzyński J, Kłopocka M, Pulkowski G, Suppan K, Fabisiak J, Majer M, Swiatkowski M. Int J Cardiol; 2008 Jul 04; 127(2):233-9. PubMed ID: 17689732 [Abstract] [Full Text] [Related]
40. Acid reflux in patients with coronary artery disease and refractory chest pain. Liu Y, He S, Chen Y, Xu J, Tang C, Tang Y, Luo G. Intern Med; 2013 Jul 04; 52(11):1165-71. PubMed ID: 23728549 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]